The value generated from the export of electro-diagnostic apparatus in Belgium increased by 78.7 million Euros (+17.91 percent) in 2024 in comparison to the previous year. With 517.9 million Euros, the value thereby reached its highest value in the observed period. Over the observed period, the value has been subject to fluctuation.

According to a survey conducted in December 2021, 84 percent of clinicians in the Asia Pacific region agreed with the statement that in ten years' time the widespread use of digital health technologies will enable a positive transformation of healthcare. Furthermore, 77 percent of clinicians surveyed in South America believed digital health will enable a positive transformation of healthcare.

In 2024, there were almost 500 digital health start-up deals funded in the United States, the third decreasing year from a peak of 740 deals in 2021. Although, the 2024 figure is still higher than in any of the years prior to the 2021 peak.

According to a survey conducted in the United States in 2022, over 36 percent of the population that had taken a genetic test were very confident in the accuracy of the results. A further 18 percent of respondents said they were completely confident with the results.

The value generated from the export of electro-cardiographs in Belgium decreased to 12.8 million Euros compared to the previous year. The year marks a significant change in the value compared to the previous year. Nevertheless, the last two years in this industry recorded a significantly higher value than the preceding years.

In December 2021, a worldwide survey found 61 percent of clinicians in China believed in ten years' time the majority of healthcare will be provided in a patient’s home instead of a healthcare setting (e.g. hospital/ clinic), the largest share among selected countries. On the other hand, a third of clinicians in the United States agreed that by 2031 the majority of healthcare will take place in a home setting.

In 2024, Johnson & Johnson was ranked as the largest global medical equipment and supply company, with sales of almost 90 billion U.S. dollars. Novartis followed in second place, with sales of around 49 billion U.S. dollars.

In 2024, digital health start-ups in the United States focused on mental health received 1.4 billion U.S. dollars in funding, making it the top funded clinical indication among digital health start-ups. Digital health start-ups focused on cardiovascular issues raised around one billion U.S. dollars in these twelve months.

The value generated from the export of ultrasonic scanning apparatus in Belgium increased by 14 million Euros (+30.53 percent) compared to the previous year. With 59.9 million Euros, the value thereby reached its highest value in the observed period.

In 2021, funding by investors in the digital health industry amounted to almost 45 billion U.S. dollars, this was double the preceding year and by far the largest amount since 2010. In 2022, funding dropped to 23.3 billion U.S. dollars, although this was still the second-highest annual figure in the provided time interval.

In 2021, the total value of venture funding towards the digital health sector in the United States amounted to approximately 29 billion U.S. dollars, the highest funding amount in the provided time interval and almost double the amount of funding from the previous year. By 2024, funding dropped to 10.1 billion U.S. dollars, the lowest amount of capital invested since 2019.

The value generated from the export of magnetic resonance imaging (MRI) equipment in Belgium decreased to 9.3 million Euros compared to the previous year. The value thereby reached its lowest value in recent years.

In 2021, there were 88 mega deals amounting to over 100 million US dollars in the digital health sector in the United States. This was the highest number of mega deals in the provided time interval. In 2022, the number of mega deals dropped to 35.

The value generated from the export of therapeutic respiration apparatus in Belgium increased by 6.5 million Euros (+27.27 percent) compared to the previous year. In total, the value amounted to 30.3 million Euros in 2024.

This statistic presents the value of medical apparatus exported from Belgium in 2023. Exports of orthopedic appliances (crutches/surgical belts and trusses) were valued at approximately 4.02 billion euros in 2023.

This statistic depicts the distribution of Medtronic's revenue in fiscal years 2021 to 2024, sorted by segment. Medtronic Inc. is a U.S.-Irish medical technology company. Medtronic has one of its headquarters in Minneapolis, Minnesota. In 2024, the company's cardiovascular segment generated over 11.8 billion U.S. dollars in revenue.

The graph presents the share of eHealth fitness product users in the United Kingdom in 2017, broken down by age group. As of 2017, it was reported that 19.6 percent of surveyed eHealth users was aged between 16 and 24 years. An overview of all Digital Markets can be found here. Statista’s Digital Market Outlook offers forecasts, detailed market insights and essential performance indicators of the most significant areas in the “Digital Economy”, including various digital goods and services. Alongside revenue forecasts for 50 countries worldwide, Statista offers additional insights into consumer trends and demographic structure of digital consumer markets.

This statistic displays the number of individuals on the liver transplant waiting list in the United Kingdom (UK) in the year ending March 2024. In England, there were 547 individuals on the liver transplant waiting list.

According to a survey of clinicians and IT decision makers carried out in the United States and the United Kingdom in 2021, 64 percent of respondents believed that telehealth had the biggest impact on healthcare services over the last year. Furthermore, 59 percent of respondents thought that connected health devices had made a large impact on healthcare.

This statistic displays the result of a survey asking respondents in England which of the following online general practice services they are aware their GP practice offers and which they had used in the last 12 months, as of 2019. Approximately 15 percent of respondents had used their GP's online service to order repeat subscriptions although over 44 percent were aware the service is available to them. Overall, over three-quarters of respondents did not use any sort of online service offered to them.